Details for New Drug Application (NDA): 020989
✉ Email this page to a colleague
The generic ingredient in EVOXAC is cevimeline hydrochloride. There are four drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cevimeline hydrochloride profile page.
Summary for 020989
Tradename: | EVOXAC |
Applicant: | Cosette |
Ingredient: | cevimeline hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 020989
Mechanism of Action | Cholinergic Muscarinic Agonists |
Suppliers and Packaging for NDA: 020989
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
EVOXAC | cevimeline hydrochloride | CAPSULE;ORAL | 020989 | NDA | Cosette Pharmaceuticals, Inc. | 0713-0883 | 0713-0883-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0713-0883-01) |
EVOXAC | cevimeline hydrochloride | CAPSULE;ORAL | 020989 | NDA | Cosette Pharmaceuticals, Inc. | 0713-0937 | 0713-0937-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0713-0937-01) |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 30MG | ||||
Approval Date: | Jan 11, 2000 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 020989
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cosette | EVOXAC | cevimeline hydrochloride | CAPSULE;ORAL | 020989-002 | Jan 11, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Cosette | EVOXAC | cevimeline hydrochloride | CAPSULE;ORAL | 020989-002 | Jan 11, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Cosette | EVOXAC | cevimeline hydrochloride | CAPSULE;ORAL | 020989-002 | Jan 11, 2000 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription